Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 4 studies | 24% ± 4% | |
erythrocyte | 4 studies | 31% ± 17% | |
erythroblast | 3 studies | 40% ± 27% |
Insufficient scRNA-seq data for expression of HTRA2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 959.42 | 1445 / 1445 | 100% | 15.37 | 183 / 183 |
ovary | 100% | 1192.09 | 180 / 180 | 100% | 27.84 | 430 / 430 |
skin | 100% | 900.88 | 1809 / 1809 | 100% | 30.90 | 472 / 472 |
thymus | 100% | 1111.73 | 653 / 653 | 100% | 24.51 | 603 / 605 |
brain | 100% | 767.67 | 2633 / 2642 | 100% | 36.14 | 705 / 705 |
lung | 100% | 1074.44 | 577 / 578 | 100% | 22.45 | 1153 / 1155 |
prostate | 100% | 846.75 | 245 / 245 | 100% | 21.46 | 500 / 502 |
breast | 100% | 1173.50 | 459 / 459 | 100% | 24.19 | 1113 / 1118 |
pancreas | 99% | 447.47 | 326 / 328 | 100% | 21.07 | 178 / 178 |
uterus | 100% | 1165.96 | 170 / 170 | 99% | 24.54 | 456 / 459 |
stomach | 100% | 717.18 | 359 / 359 | 99% | 19.71 | 284 / 286 |
intestine | 100% | 1054.83 | 966 / 966 | 99% | 22.08 | 523 / 527 |
kidney | 100% | 894.73 | 89 / 89 | 99% | 22.47 | 893 / 901 |
bladder | 100% | 1041.48 | 21 / 21 | 99% | 24.03 | 498 / 504 |
liver | 100% | 511.98 | 226 / 226 | 99% | 15.37 | 400 / 406 |
adrenal gland | 100% | 1057.81 | 258 / 258 | 97% | 20.60 | 223 / 230 |
adipose | 100% | 1220.87 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1141.45 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 27.73 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 37.92 | 29 / 29 |
muscle | 100% | 713.24 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1479.01 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.48 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 15.81 | 1 / 1 |
heart | 99% | 697.21 | 856 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 1136.50 | 923 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0007628 | Biological process | adult walking behavior |
GO_0045786 | Biological process | negative regulation of cell cycle |
GO_0034605 | Biological process | cellular response to heat |
GO_0035694 | Biological process | mitochondrial protein catabolic process |
GO_0012501 | Biological process | programmed cell death |
GO_0030900 | Biological process | forebrain development |
GO_0016540 | Biological process | protein autoprocessing |
GO_0006672 | Biological process | ceramide metabolic process |
GO_1902176 | Biological process | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
GO_0040014 | Biological process | regulation of multicellular organism growth |
GO_0071363 | Biological process | cellular response to growth factor stimulus |
GO_0019742 | Biological process | pentacyclic triterpenoid metabolic process |
GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_1903146 | Biological process | regulation of autophagy of mitochondrion |
GO_0035458 | Biological process | cellular response to interferon-beta |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0007005 | Biological process | mitochondrion organization |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0048666 | Biological process | neuron development |
GO_0006508 | Biological process | proteolysis |
GO_0008630 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage |
GO_0009635 | Biological process | response to herbicide |
GO_0030163 | Biological process | protein catabolic process |
GO_0097194 | Biological process | execution phase of apoptosis |
GO_1903955 | Biological process | positive regulation of protein targeting to mitochondrion |
GO_2001241 | Biological process | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_1904924 | Biological process | negative regulation of mitophagy in response to mitochondrial depolarization |
GO_1900119 | Biological process | positive regulation of execution phase of apoptosis |
GO_0005856 | Cellular component | cytoskeleton |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005758 | Cellular component | mitochondrial intermembrane space |
GO_0035631 | Cellular component | CD40 receptor complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_1905370 | Cellular component | serine-type endopeptidase complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0008233 | Molecular function | peptidase activity |
GO_1990948 | Molecular function | ubiquitin ligase inhibitor activity |
GO_0030291 | Molecular function | protein serine/threonine kinase inhibitor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0008236 | Molecular function | serine-type peptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | HTRA2 |
Protein name | Mitochondrial serine protease Epididymis secretory sperm binding protein (HtrA serine peptidase 2, isoform CRA_e) Serine protease HTRA2, mitochondrial Serine protease HTRA2, mitochondrial (EC 3.4.21.108) (High temperature requirement protein A2) (HtrA2) (Omi stress-regulated endoprotease) (Serine protease 25) (Serine proteinase OMI) HtrA serine peptidase 2 |
Synonyms | hCG_41061 OMI PRSS25 |
Description | FUNCTION: Serine protease that shows proteolytic activity against a non-specific substrate beta-casein. Promotes or induces cell death either by direct binding to and inhibition of BIRC proteins (also called inhibitor of apoptosis proteins, IAPs), leading to an increase in caspase activity, or by a BIRC inhibition-independent, caspase-independent and serine protease activity-dependent mechanism. Cleaves THAP5 and promotes its degradation during apoptosis. Isoform 2 seems to be proteolytically inactive. . |
Accessions | ENST00000437202.1 ENST00000696727.1 O43464 ENST00000352222.7 [O43464-2] ENST00000696728.1 ENST00000258080.8 [O43464-1] ENST00000437202.2 [O43464-3] A0A0C4DG44 A0A384MDW9 B2BKJ3 A0A8Q3SJ36 A0A8Q3SIX7 |